Argininosuccinate synthase as a novel biomarker for inflammatory conditions

References

• Balkwill F, Charles KA, Mantovani A. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211–17
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. (2001). Inflammation and cancer: back to Virchow?. Lancet 357:539–45
   PubMed Web of Science ®Google Scholar
• Becker KL, Snider R, Nylen ES. (2010). Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol 159:253–64
   PubMed Web of Science ®Google Scholar
• Bending D, Zaccone P, Cooke A. (2012). Inflammation and type one diabetes. Int Immunol 24:339–46
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
   PubMed Web of Science ®Google Scholar
• Cao M, Xu Y, Youn JI, et al. (2011). Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Lab Invest 91:598–608
   PubMed Web of Science ®Google Scholar
• Chung KF. (2012). Inflammatory biomarkers in severe asthma. Curr Opin Pulm Med 18:35–41
   PubMed Web of Science ®Google Scholar
• Clyne B, Olshaker JS. (1999). The C-reactive protein. J Emerg Med 17:1019–25
   PubMed Web of Science ®Google Scholar
• Coussens LM, Raymond WW, Bergers G, et al. (1999). Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382–97
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420:860–7
   PubMed Web of Science ®Google Scholar
• Delano MJ, Scumpia PO, Weinstein JS, et al. (2007). MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204:1463–74
   PubMed Web of Science ®Google Scholar
• Dellinger RP, Levy MM, Carlet JM, et al. (2008). Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327
   PubMed Web of Science ®Google Scholar
• Dvorak HF. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–9
   PubMed Web of Science ®Google Scholar
• Fernandes-Santos C, Evangelista Carneiro R, de Souza Mendonca L, et al. (2009). Rosiglitazone aggravates nonalcoholic fatty pancreatic disease in C57BL/6 mice fed high-fat and high-sucrose diet. Pancreas 38:e80–6
   Google Scholar
• Foltz CJ, Fox JG, Cahill R, et al. (1998). Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3:69–78
   PubMed Web of Science ®Google Scholar
• Gullo A, Bianco N, Berlot G. (2006). Management of severe sepsis and septic shock: challenges and recommendations. Crit Care Clin 22:489–501
   Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87–91
   PubMed Web of Science ®Google Scholar
• Hotchkiss RS, Karl IE. (2003). The pathophysiology and treatment of sepsis. N Engl J Med 348:138–50
   PubMed Web of Science ®Google Scholar
• Husson A, Brasse-Lagnel C, Fairand A, et al. (2003). Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 270:1887–99
   PubMedGoogle Scholar
• Karin M. (2005). Inflammation and cancer: the long reach of Ras. Nature Med 11:20–1
   PubMed Web of Science ®Google Scholar
• Karin M. (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441:431–6
   PubMed Web of Science ®Google Scholar
• Kobayashi E, Masuda M, Nakayama R, et al. (2010). Reduced argininosuccinate synthetase is a predictive biomarker for the development of pulmonary metastasis in patients with osteosarcoma. Mol Cancer Ther 9:535–44
   Google Scholar
• Kumar A, Roberts D, Wood KE, et al. (2006). Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–96
   PubMed Web of Science ®Google Scholar
• Kuper H, Adami HO, Trichopoulos D. (2000). Infections as a major preventable cause of human cancer. J Intern Med 248:171–83
   PubMed Web of Science ®Google Scholar
• Lever A, Mackenzie I. (2007). Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879–83
   PubMed Web of Science ®Google Scholar
• Marshall JC, Reinhart K. (2009). Biomarkers of sepsis. Crit Care Med 37: 2290–8
   PubMed Web of Science ®Google Scholar
• Mueller MM, Fusenig NE. (2004). Friends or foes – bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4:839–49
   PubMed Web of Science ®Google Scholar
• Ohno T, Kimura Y, Sakurada K, et al. (1992). Argininosuccinate synthetase gene expression in leukemias: potential diagnostic marker for blastic crisis of chronic myelocytic leukemia. Leuk Res 16:475–83
   Google Scholar
• Opal SM. (2007). The host response to endotoxin, antilipopolysaccharide strategies, and the management of severe sepsis. Int J Med Microbiol 297:365–77
   PubMed Web of Science ®Google Scholar
• Patek PQ, Collins JL, Cohn M. (1978). Transformed cell lines susceptible or resistant to in vivo surveillance against tumorigenesis. Nature 276:510–11
   PubMed Web of Science ®Google Scholar
• Percik R, Stumvoll M. (2009). Obesity and cancer. Exp Clin Endocrinol Diabetes 117:563–6
   Google Scholar
• Pimentel GD, Dornellas AP, Rosa JC, et al. (2012). High-fat diets rich in soy or fish oil distinctly alter hypothalamic insulin signaling in rats. J Nutr Biochem 23:822–8
   Google Scholar
• Póvoa P, Coelho L, Almeida E, et al. (2005). C-reactive protein as a marker of infection in critically ill patients. Clin Microbiol Infect 11:101–8
   PubMed Web of Science ®Google Scholar
• Pradhan AD, Manson JE, Rifai N, et al. (2001). C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327–34
   PubMed Web of Science ®Google Scholar
• Prima V, Cao M, Svetlov SI. (2013). ASS and SULT2A1 are novel and sensitive biomarkers of acute hepatic injury – a comparative study in animal models. J Liver (omics), in press
   Google Scholar
• Prima V, Wang A, Molina G, et al. (2011). Inhibition of LPS toxicity by hepatic argininosuccinate synthase (ASS): novel roles for ASS in innate immune responses to bacterial infection. Int Immunopharmacol 11:1180–8
   PubMedGoogle Scholar
• Qian L, Flood PM, Hong JS. (2010). Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Trans 117:971–9
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, et al. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347:1557–65
   PubMed Web of Science ®Google Scholar
• Rivers EP, McIntyre L, Morro DC, Rivers KK. (2005). Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 173:1054–65
   PubMed Web of Science ®Google Scholar
• Schmit X, Vincent JL. (2008). The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 36:213–19
   PubMed Web of Science ®Google Scholar
• Shacter E, Weitzman SA. (2002). Chronic inflammation and cancer. Oncology 16:217–32
   PubMed Web of Science ®Google Scholar
• Sun B, Karin M. (2012). Obesity, inflammation, and liver cancer. J Hepatol 56:704–13
   PubMed Web of Science ®Google Scholar
• Svetlov SI, Xiang Y, Oli MW, et al. (2006). Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches. Biomarkers 11:355–69
   PubMed Web of Science ®Google Scholar
• Szlosarek PW, Klabatsa A, Pallaska A, et al. (2006). In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion. Clin Cancer Res 12:7126–31
   PubMed Web of Science ®Google Scholar
• Taube A, Schlich R, Sell H, et al. (2012). Inflammation and metabolic dysfunction: links to cardiovascular diseases. Am J Physiol Heart Circ Physiol 302:H2148–65
   PubMed Web of Science ®Google Scholar
• Trayhurn P, Wood IS. (2005). Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33:1078–81
   PubMed Web of Science ®Google Scholar
• Trinchieri G. (2012). Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol 30:677–706
   PubMed Web of Science ®Google Scholar
• Tuppo EE, Arias Hugo R. (2005). The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 37:289–305
   PubMed Web of Science ®Google Scholar
• Zambon M, Ceola M, Almeida-de-Castro R, et al. (2008). Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 23:455–60
   PubMed Web of Science ®Google Scholar